Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants
- 29 July 2004
- Vol. 22 (21-22) , 2836-2842
- https://doi.org/10.1016/j.vaccine.2004.01.044
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The estimation of mortality due to rotavirus infections in sub-Saharan AfricaVaccine, 2000
- Possible Association of Intussusception With Rotavirus VaccinationPublished by American Academy of Pediatrics (AAP) ,1999
- Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countriesVaccine, 1999
- Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine.Clinical Infectious Diseases, 1998
- Cost-effectiveness Analysis of a Rotavirus Immunization Program for the United StatesJAMA, 1998
- Rotavirus vaccines against diarrhoeal diseaseThe Lancet, 1997
- Efficacy of the Rhesus Rotavirus–Based Quadrivalent Vaccine in Infants and Young Children in VenezuelaNew England Journal of Medicine, 1997
- Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populationsThe Journal of Pediatrics, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- Review Of Rotavirus Vaccine Trials In FinlandThe Journal of Infectious Diseases, 1996